Concepedia

Author

D. Lutz

Krankenhaus der Elisabethinen

Also Known As

D Ieter Lutz, D Lutz, D. LUTZ, D. Lutz, DIETER LUTZ, DJENIFER LUANA LUTZ, Danny Lutz, Dieter Lutz, H. Tüchler

136

Publications

1.8K

Citations

24

H-Index

51

Concepts

All Affiliations

Krankenhaus der ElisabethinenHanusch HospitalUniversity of ViennaLudwig Boltzmann Institute for Cancer ResearchMedical University of Vienna
DL

About

D. Lutz is an author at Krankenhaus der Elisabethinen specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

354

2

Health Sciences

3

3

91

3

Engineering

1

1

17

4

Natural Sciences

1

1

29

5

Allergy

1

1

47

D. Lutz

×

31

Publications

1.5K

Citations

22

H-Index

YearCitations

Myeloid differentiation antigen defined by a monoclonal antibody

Otto Majdic, K Liszka, D. Lutz,

Blood

1981

168

Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNA

Otto Zach, H. Kasparu, Otto Krieger,

Journal of Clinical Oncology

1999

155

M2, A novel myelomonocytic cell surface antigen and its distribution on leukemic cells

Otto Majdic, Peter Bettelheim, Hannes Stockinger,

International Journal of Cancer

1984

101

Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology

Wolfgang R. Sperr, Aischa El-Samahi, Michael Kundi,

European Journal of Clinical Investigation

2009

99

DEVELOPMENT OF A REGIONAL COHORT OF VERY‐LOW‐BIRTHWEIGHT CHILDREN AT SIX YEARS: COGNITIVE ABILITIES ARE ASSOCIATED WITH NEUROLOGICAL DISABILITY AND SOCIAL BACKGROUND

Olaf Dammann, Heike Walther, Barbara Alters,

Developmental Medicine & Child Neurology

1996

98

Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia

Peter Bettelheim, D. Lutz, Otto Majdic,

British Journal of Haematology

1985

98

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia

Branimir Jakšić, Maura Brugiatelli, Ivo Krc,

Cancer

1997

87

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome

I Simonitsch-Klupp, I Häuser, German Ott,

Leukemia

2003

55

Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996)

Helena Jernberg, Kenneth Nilsson, L. Zech,

Blood

1987

54

Exposure by Desialylation of Myeloid Antigens on Acute Lymphoblastic Leukemia Cells<xref ref-type="fn" rid="FN2">2</xref>

Hannes Stockinger, Otto Majdic, K Liszka,

JNCI Journal of the National Cancer Institute

1984

47

Page 1